Evidence map›Paper›PMID 36927233›Full record

ArticleTechnology in cancer research & treatment

PRMT5/FGFR3/AKT Signaling Axis Facilitates Lung Cancer Cell Metastasis.

Yonghua Zheng, Jingjing Lu, Xiaoyan Hu, Xiaobiao Hu, Xiwen Gao, Jie Zhou

Open access · goldAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Technology in cancer research & treatment. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
1.2field-weighted citation impact, top 21% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 8 citations in OpenAlex.

  1. Review
  2. Article
  3. A Further Case for Targeting PRMT5 and the ERK1/2 and PI3K Pathways in CRC.International journal of molecular sciences · 2025
    Article
  4. Review
  5. Review
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 2 institutions in 1 country.

Yonghua ZhengDepartment of Pulmonary Medicine, Shanghai Jinshan Tinglin Hospital, Shanghai, P.R. China.ORCID 0000-0002-7799-9612
Jingjing LuDepartment of Pulmonary and Critical Care Medicine, 66324Shanghai East Hospital, Tongji University School of Medicine, Shanghai, P.R. China.ORCID 0000-0003-2841-3117
Xiaoyan HuDepartment of Pulmonary Medicine, Shanghai Jinshan Tinglin Hospital, Shanghai, P.R. China.
Xiaobiao HuDepartment of Pulmonary Medicine, Shanghai Jinshan Tinglin Hospital, Shanghai, P.R. China.
Xiwen GaoDepartment of Pulmonary and Critical Care Medicine, Minhang Hospital, Fudan University, Shanghai, P.R. China.
Jie ZhouDepartment of Pulmonary and Critical Care Medicine, Minhang Hospital, Fudan University, Shanghai, P.R. China.
Fudan University · CNShanghai East Hospital · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Lung NeoplasmsProto-Oncogene Proteins c-aktHumansProtein-Arginine N-MethyltransferasesReceptor, Fibroblast Growth Factor, Type 3RNA, Small InterferingSignal TransductionFGFR3 protein, humanPRMT5 protein, humanProtein-Arginine N-MethyltransferasesProto-Oncogene Proteins c-aktReceptor, Fibroblast Growth Factor, Type 3RNA, Small InterferingAKTEMTFGFR3lung cancermetastasisPRMT5

Identifiers

PMID36927233
PMCPMC10026111
OpenAlexW4327680701

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.